B A S E C A R E
Powerful combination丨BASECARE and DIAN DIAGNOSTICS reached a strategic cooperation agreement to jointly develop China’ reproductive market.
22th May 2020 · Suzhou
On May 22, 2020, Suzhou Basecare Medical Device Co., Ltd. (hereinafter referred to as "Basecare ") and Dian diagnostic technology group Co. Ltd. (hereinafter referred to as "dian diagnostic") held an online cooperation signing ceremony

On May 22, 2020,Suzhou Basecare Medical Device Co., Ltd. (hereinafter referred to as "Basecare") and Dian diagnostic technology group Co. Ltd. (hereinafter referred toas "dean diagnostic") held an online cooperation signing ceremony, and the two sides signed a strategic cooperation agreement to jointly develop the market for third-party medical testing in the field of reproduction, and provide more than 500 reproductive centers across the country with comprehensive third-party testing service packages covering 3,000 types of integrated projects, ranging from basic physiological, biochemical, immune and virusdetection to molecular genetic testing.
Basecare is a leading enterprise in the field of reproduction in the NGS market segment. The preimplantation genetic testing for aneuploidy (PGT-A) kit is the first PGT-A product approved by the National Medical products Administration. According to the strategic agreement, the two sides will give full play to their respective advantages, help each other, and jointly promote the comprehensive application of birth cycle products in the third-party medical examination platform.